Valuation: Balchem Corporation

Market Cap 550.13Cr 482.35Cr 444.62Cr 416.25Cr 780.54Cr 52TCr 796.75Cr 5.34TCr 2.07TCr 26TCr 2.07TCr 2.02TCr 89TCr P/E 2026 *
32.7x
P/E 2027 * 31.1x
Enterprise Value 553.32Cr 485.16Cr 447.2Cr 418.67Cr 785.08Cr 52TCr 801.38Cr 5.38TCr 2.08TCr 26TCr 2.08TCr 2.03TCr 89TCr EV / Sales 2026 *
5x
EV / Sales 2027 * 4.69x
Free-Float
99.53%
Yield 2026 *
0.66%
Yield 2027 * 0.74%
1 day-1.04%
1 week+2.02%
Current month+7.77%
1 month+7.77%
3 months-0.90%
6 months+7.81%
Current year+10.14%
1 week 165.44
Extreme 165.44
174.09
1 month 152.91
Extreme 152.91
174.09
Current year 152.58
Extreme 152.58
183.9
1 year 139.17
Extreme 139.17
183.9
3 years 110.74
Extreme 110.74
186.03
5 years 110.15
Extreme 110.1456
186.03
10 years 57.64
Extreme 57.64
186.03
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2015
Director of Finance/CFO 49 04/02/2019
Chief Tech/Sci/R&D Officer 56 01/10/2025
Director TitleAgeSince
Director/Board Member 63 16/09/2010
Chairman 61 01/01/2017
Director/Board Member 59 15/09/2015
Date Insider Type Main position Quantity % Market Cap.
01/04Other

Controller/Auditor

8,646 0.0270%
11/02Free

Director

870 0.0027%
11/02Free

Director

870 0.0027%
Change 5-day change 1-year change 3-year change Capi.($)
-1.10%+2.02%+6.10%+25.45% 550.13Cr
-1.05%+4.15%+4.11%+52.56% 7.98TCr
+0.31%+4.86%-11.25%+17.23% 3.87TCr
-2.40%+0.58%-23.61%-33.38% 3.33TCr
+2.24%+4.43%+11.81%+22.29% 2.54TCr
-3.69%-12.52%+95.07%-3.74% 2.04TCr
-1.22%-2.40%+15.44%+3.75% 2.02TCr
-2.97%-8.24%-35.53%-37.60% 1.85TCr
-3.71%-17.86%+105.36%-41.23% 1.58TCr
-0.41%+2.01%-1.17%-6.42% 1.39TCr
Average -1.39%-1.27%+16.63%-0.11% 2.72TCr
Weighted average by Cap. -1.15%+0.73%+9.88%+11.13%

Financials

2026 *2027 *
Net sales 110.64Cr 97Cr 89Cr 84Cr 156.98Cr 10TCr 160.24Cr 1.07TCr 415.87Cr 5.16TCr 415.45Cr 406.37Cr 18TCr 116.5Cr 102.14Cr 94Cr 88Cr 165.29Cr 11TCr 168.72Cr 1.13TCr 437.88Cr 5.43TCr 437.44Cr 427.89Cr 19TCr
Net income 17Cr 15Cr 14Cr 13Cr 24Cr 1.6TCr 25Cr 164.79Cr 64Cr 790.87Cr 64Cr 62Cr 2.74TCr 18Cr 16Cr 14Cr 14Cr 25Cr 1.68TCr 26Cr 173.48Cr 67Cr 832.6Cr 67Cr 66Cr 2.89TCr
Net Debt 3.2Cr 2.8Cr 2.58Cr 2.42Cr 4.54Cr 301.65Cr 4.63Cr 31Cr 12Cr 149.08Cr 12Cr 12Cr 516.95Cr -4.03Cr -3.53Cr -3.25Cr -3.05Cr -5.71Cr -379.8Cr -5.83Cr -39Cr -15Cr -187.71Cr -15Cr -15Cr -650.88Cr
Logo Balchem Corporation
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Employees
1,368
Date Price Change Volume
29/26/29 $168.91 -1.35% 32,902
26/26/26 $171.22 +1.18% 7,61,793
25/26/25 $169.23 -0.03% 1,86,984
24/26/24 $169.28 +1.95% 2,07,155
23/26/23 $166.04 +0.28% 1,82,921
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
171.22USD
Average target price
200.75USD
Spread / Average Target
+17.25%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BCPC Stock